Ranibizumab, panretinal photocoagulation both effective for PDR
- Posted on: Aug 17 2018
- Leave a response
This study compares the efficacy and safety of intravitreous ranibizumab versus panretinal photocoagulation over 5 years of treatment in patients with proliferative diabetic retinopathy.
Source: AAO
Posted in: Uncategorized
